Why the study?
Does preoperative intraarterial adriamycin and radiation therapy improve outcomes in patients with extremity soft tissue sarcomas compared to operation alone?
Does preoperative intraarterial adriamycin and radiation therapy improve outcomes in patients with extremity soft tissue sarcomas compared to operation alone?
Answers are grounded in this paper and cite their sources.
This article discusses institutional experience with adjuvant treatment techniques, including preoperative intraarterial adriamycin and radiation therapy, for extremity soft tissue sarcomas to improve upon the high failure rates of surgery alone.
Surgical therapy has been the accepted method for management of most soft tissue sarcomas of the extremities, although it has been associated frequently with local treatment failure. Even when local control was achieved, over 50% of the patients with soft tissue sarcomas eventually developed and succumbed to distant metastases of their disease. Therefore, single modality therapy for soft tissue sarcomas by operation alone results in an unacceptably high incidence of treatment failure. Fortunately, new adjuvant treatment techniques have been developed that seem to have activity against these neoplasms. It is the purpose of this article to discuss our experience with a number of these techniques.
No takes yet. Share an insight, caveat, or question.
Morton et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: